Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Migueles

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Immunology Letters|October 12, 2001
Frequency and function of HIV-specific CD8(+) T cellsS A Migueles, M Connors
HIV Medicine|February 26, 2015
Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialM G Law, A Achhra, S G Deeks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Status of activation of circulating vaccine-elicited CD8+ T cellsM B Nielsen, V Monsurro, S A Migueles, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2000
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressorsS A Migueles, M S Sabbaghian, W L Shupert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressorsJ C Gea-Banacloche, S A Migueles, L Martino, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2001
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parametersM Dybul, T W Chun, C Yoder, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Immunology Letters|October 12, 2001
Frequency and function of HIV-specific CD8(+) T cellsS A Migueles, M Connors
HIV Medicine|February 26, 2015
Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialM G Law, A Achhra, S G Deeks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Status of activation of circulating vaccine-elicited CD8+ T cellsM B Nielsen, V Monsurro, S A Migueles, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2000
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressorsS A Migueles, M S Sabbaghian, W L Shupert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressorsJ C Gea-Banacloche, S A Migueles, L Martino, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2001
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parametersM Dybul, T W Chun, C Yoder, et al.
Pageof 1